ILOPROST

ILOPROST was reported 932 times

ILOPROST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR RESISTANCE PULMONARY DECREASED 6 0.3158
1 ARTERIAL SWITCH OPERATION 1 0.2000
2 LUNG VOLUME REDUCTION SURGERY 2 0.1250
3 ARRHYTHMOGENIC CARDIOMYOPATHY 1 0.1111
4 SPONTANEOUS INTRAHEPATIC PORTOSYSTEMIC VENOUS SHUNT 1 0.0833
5 CORONARY ARTERY COMPRESSION 2 0.0800
6 MULTIPLE EPIPHYSEAL DYSPLASIA 2 0.0741
7 BALLOON ATRIAL SEPTOSTOMY 3 0.0625
8 MITRAL PERFORATION 1 0.0625
9 AUTOIMMUNE VASCULITIS 1 0.0588
10 ANNULOPLASTY 1 0.0588
11 ARTERIAL ANEURYSM REPAIR 1 0.0556
12 GASTRIC POLYPECTOMY 1 0.0455
13 ARTERIAL ANGIOPLASTY 1 0.0370
14 SYSTEMIC SCLEROSIS 8 0.0369
15 PULMONARY VASCULAR RESISTANCE ABNORMALITY 3 0.0349
16 VASCULAR RESISTANCE PULMONARY INCREASED 3 0.0349
17 NEONATAL PNEUMONIA 8 0.0340
18 DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN 1 0.0323
19 HCOV-OC43 INFECTION 1 0.0323
20 PUNCTURE SITE INFECTION 2 0.0323
21 SYSTEMIC-PULMONARY ARTERY SHUNT 1 0.0312
22 CHONDRODYSTROPHY 2 0.0253
23 STERNOTOMY 1 0.0244
24 LEFT-TO-RIGHT CARDIAC SHUNT 7 0.0237
25 PULMONARY FUNCTION TEST INCREASED 1 0.0233
26 WHITE CLOT SYNDROME 1 0.0233
27 CARDIAC INDEX INCREASED 1 0.0227
28 EXTRACORPOREAL MEMBRANE OXYGENATION 1 0.0222
29 URTICARIA PIGMENTOSA 1 0.0222
30 PULMONARY HYPERTENSIVE CRISIS 6 0.0221
31 NEONATAL HYPOTENSION 8 0.0217
32 PULMONARY ARTERIAL PRESSURE 1 0.0213
33 PERIPORTAL SINUS DILATATION 1 0.0185
34 MENINGOENCEPHALITIS VIRAL 3 0.0169
35 CERVICAL CONISATION 1 0.0149
36 CARDIAC ARREST NEONATAL 2 0.0145
37 SKELETAL DYSPLASIA 2 0.0141
38 VENOUS OXYGEN SATURATION DECREASED 1 0.0141
39 PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY 1 0.0130
40 PULMONARY ARTERY ANEURYSM 2 0.0123
41 ABORTION LATE 1 0.0120
42 BRAIN NATRIURETIC PEPTIDE DECREASED 1 0.0119
43 PULMONARY ARTERY DILATATION 4 0.0116
44 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 1 0.0112
45 FINGER AMPUTATION 8 0.0109
46 VENTRICULAR INTERNAL DIAMETER ABNORMAL 1 0.0105
47 CONGENITAL ARTERIAL MALFORMATION 2 0.0104
48 BLOOD PRODUCT TRANSFUSION 1 0.0104
49 RIGHT VENTRICULAR DILATATION 6 0.0104
50 MEDIASTINAL HAEMORRHAGE 1 0.0103
51 BRACHYDACTYLY 2 0.0102
52 EOSINOPHILIC PNEUMONIA CHRONIC 3 0.0101
53 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 14 0.0100
54 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 2 0.0093
55 SUBCLAVIAN ARTERY THROMBOSIS 1 0.0092
56 RIGHT VENTRICULAR FAILURE 64 0.0091
57 FLUID INTAKE RESTRICTION 1 0.0091
58 OXYGEN SATURATION IMMEASURABLE 1 0.0091
59 PLEURAL THICKENING 6 0.0088
60 OVARIAN RUPTURE 1 0.0085
61 CREST SYNDROME 2 0.0084
62 ENVIRONMENTAL EXPOSURE 2 0.0084
63 MENSTRUAL DISCOMFORT 1 0.0083
64 PULMONARY RESECTION 2 0.0081
65 PULMONARY ARTERY STENOSIS 3 0.0077
66 AORTIC SURGERY 1 0.0076
67 EXTREMITY NECROSIS 13 0.0074
68 OVARIAN CANCER METASTATIC 6 0.0071
69 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 1 0.0070
70 SYMPTOM MASKED 5 0.0069
71 PERITONEAL HAEMATOMA 1 0.0067
72 AIRWAY PEAK PRESSURE INCREASED 1 0.0066
73 FOETAL GROWTH ABNORMALITY 1 0.0064
74 HAEMOSTASIS 1 0.0061
75 HEPATOJUGULAR REFLUX 1 0.0060
76 ATRIAL SEPTAL DEFECT REPAIR 1 0.0058
77 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 1 0.0057
78 PULMONARY VENO-OCCLUSIVE DISEASE 4 0.0057
79 ABDOMINAL STRANGULATED HERNIA 1 0.0055
80 ERYTHROMELALGIA 2 0.0055
81 GRANULOMATOUS LYMPHADENITIS 1 0.0053
82 ANASTOMOTIC HAEMORRHAGE 1 0.0053
83 CRYPTOGENIC ORGANIZING PNEUMONIA 1 0.0052
84 RESPIRATORY TRACT HAEMORRHAGE 3 0.0050
85 CHRONIC RESPIRATORY FAILURE 6 0.0050
86 RESPIRATORY DISORDER NEONATAL 8 0.0049
87 TRANSFERRIN SATURATION DECREASED 2 0.0047
88 BRAIN NATRIURETIC PEPTIDE ABNORMAL 1 0.0047
89 CONGENITAL MUSCULOSKELETAL ANOMALY 2 0.0045
90 CONGESTIVE HEPATOPATHY 2 0.0045
91 OVARIAN HAEMORRHAGE 1 0.0042
92 PERICARDIAL DRAINAGE 1 0.0042
93 PNEUMOTHORAX TRAUMATIC 1 0.0041
94 PULMONARY ARTERIAL HYPERTENSION 59 0.0041
95 DNA ANTIBODY POSITIVE 1 0.0040
96 RIGHT ATRIAL DILATATION 2 0.0039
97 TRANSPLANT EVALUATION 2 0.0039
98 AORTA HYPOPLASIA 1 0.0038
99 BRONCHOPULMONARY DYSPLASIA 3 0.0037
100 PULMONARY ARTERIAL PRESSURE INCREASED 6 0.0037
101 ANTITHROMBIN III DECREASED 1 0.0037
102 COLONIC PSEUDO-OBSTRUCTION 1 0.0036
103 PULMONARY ARTERIAL PRESSURE ABNORMAL 1 0.0035
104 TRANSAMINASES ABNORMAL 2 0.0034
105 PERSISTENT FOETAL CIRCULATION 2 0.0033
106 TACHYARRHYTHMIA 8 0.0032
107 VENTRICULAR FAILURE 1 0.0032
108 VASCULAR COMPRESSION 1 0.0032
109 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 1 0.0032
110 CYANOSIS NEONATAL 2 0.0031
111 ILEAL PERFORATION 2 0.0030
112 LOW CARDIAC OUTPUT SYNDROME 1 0.0030
113 VASCULAR DEVICE OCCLUSION 1 0.0029
114 POLYHYDRAMNIOS 3 0.0029
115 CHOLURIA 1 0.0029
116 SOFT TISSUE NECROSIS 2 0.0029
117 SPERM CONCENTRATION DECREASED 1 0.0029
118 PULMONARY ALVEOLAR HAEMORRHAGE 16 0.0028
119 SYSTOLIC DYSFUNCTION 3 0.0028
120 ANOXIA 1 0.0028
121 NEONATAL ASPHYXIA 2 0.0028
122 INTENSIVE CARE 4 0.0028
123 VENOUS PRESSURE JUGULAR INCREASED 1 0.0028
124 SCLERODERMA RENAL CRISIS 1 0.0026
125 MEDIASTINAL MASS 1 0.0026
126 WALKING DISTANCE TEST ABNORMAL 1 0.0026
127 METASTATIC LYMPHOMA 1 0.0026
128 MITRAL VALVE REPLACEMENT 1 0.0025
129 LOW BIRTH WEIGHT BABY 20 0.0025
130 LUNG DIFFUSION TEST DECREASED 1 0.0025
131 HAEMOPERITONEUM 2 0.0025
132 ARTERY DISSECTION 1 0.0024
133 ARTERIAL THROMBOSIS LIMB 1 0.0024
134 HYPOCAPNIA 1 0.0024
135 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
136 NOCTURNAL DYSPNOEA 3 0.0024
137 LIPOMA 6 0.0023
138 SARCOPENIA 1 0.0023
139 LUNG TRANSPLANT 8 0.0023
140 FEEDING INTOLERANCE 1 0.0022
141 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
142 BUNDLE BRANCH BLOCK 2 0.0021
143 MASTOCYTOSIS 1 0.0021
144 CRANIAL NERVE PARALYSIS 1 0.0021
145 COR PULMONALE 2 0.0021
146 CONCOMITANT DISEASE PROGRESSION 4 0.0020
147 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0020
148 SUBCUTANEOUS EMPHYSEMA 2 0.0020
149 PULMONARY HYPERTENSION 41 0.0020
150 PULMONARY VASCULITIS 1 0.0019
151 HAEMODYNAMIC INSTABILITY 14 0.0018
152 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
153 JUGULAR VEIN DISTENSION 1 0.0018
154 EYE ULCER 1 0.0017
155 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
156 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
157 PARACENTESIS 1 0.0016
158 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
159 BLOOD BILIRUBIN DECREASED 1 0.0016
160 SMALL FOR DATES BABY 8 0.0016
161 ARTERITIS 1 0.0016
162 CATHETERISATION CARDIAC 7 0.0016
163 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
164 SICKLE CELL ANAEMIA 1 0.0016
165 CELLULITIS STAPHYLOCOCCAL 1 0.0015
166 FORCED VITAL CAPACITY DECREASED 1 0.0015
167 BICYTOPENIA 3 0.0015
168 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
169 GANGRENE 9 0.0015
170 PARANEOPLASTIC SYNDROME 1 0.0015
171 FOETAL EXPOSURE DURING DELIVERY 1 0.0015
172 PROTHROMBIN TIME ABNORMAL 1 0.0014
173 DILATATION VENTRICULAR 3 0.0014
174 BRONCHIAL OBSTRUCTION 2 0.0014
175 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
176 INFUSION SITE INFLAMMATION 1 0.0014
177 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
178 SYSTEMIC SCLERODERMA 1 0.0014
179 HEART SOUNDS ABNORMAL 1 0.0013
180 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
181 CAUDA EQUINA SYNDROME 1 0.0013
182 PULMONARY HYPOPLASIA 1 0.0013
183 SUPERINFECTION BACTERIAL 1 0.0013
184 NECROSIS 7 0.0013
185 PREMATURE DELIVERY 20 0.0013
186 ELECTROMECHANICAL DISSOCIATION 1 0.0013
187 POLYPECTOMY 1 0.0013
188 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
189 VASCULAR ACCESS COMPLICATION 1 0.0012
190 VACCINATION COMPLICATION 1 0.0012
191 FUNGAL SEPSIS 1 0.0012
192 BRADYCARDIA FOETAL 1 0.0012
193 MYOCARDIAL FIBROSIS 1 0.0012
194 SPLEEN DISORDER 2 0.0012
195 PROCEDURAL HYPOTENSION 1 0.0012
196 PREMATURE BABY 35 0.0012
197 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
198 CARDIAC OUTPUT DECREASED 1 0.0011
199 PRODUCT SUPPLY ISSUE 8 0.0011
200 HYPERLACTACIDAEMIA 3 0.0011
201 PNEUMOMEDIASTINUM 2 0.0011
202 CARDIAC DYSFUNCTION 4 0.0011
203 ENDOTRACHEAL INTUBATION 3 0.0011
204 NASAL OBSTRUCTION 2 0.0011
205 NEONATAL RESPIRATORY DISTRESS 1 0.0011
206 HEPATIC CONGESTION 1 0.0011
207 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
208 PYELONEPHRITIS 9 0.0010
209 COARCTATION OF THE AORTA 1 0.0010
210 COMA SCALE ABNORMAL 3 0.0010
211 PULMONARY PAIN 3 0.0010
212 SUDDEN HEARING LOSS 2 0.0010
213 HYPOCHROMIC ANAEMIA 1 0.0010
214 VASCULAR STENT THROMBOSIS 2 0.0010
215 BREAST DISCOMFORT 1 0.0010
216 METASTASES TO PLEURA 1 0.0010
217 ATRIAL TACHYCARDIA 2 0.0010
218 HAEMATOTOXICITY 9 0.0009
219 ORTHOPNOEA 3 0.0009
220 NEUROMYOPATHY 1 0.0009
221 INJECTION SITE INFECTION 3 0.0009
222 PEPTIC ULCER 3 0.0009
223 SOFT TISSUE DISORDER 1 0.0009
224 CATHETER SITE DISCHARGE 1 0.0009
225 IMMUNE-MEDIATED HYPOTHYROIDISM 1 0.0009
226 PO2 DECREASED 1 0.0009
227 IRON DEFICIENCY ANAEMIA 8 0.0009
228 LARGE INTESTINE POLYP 6 0.0009
229 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
230 CAESAREAN SECTION 10 0.0009
231 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
232 BILIRUBIN CONJUGATED INCREASED 2 0.0009
233 SENSE OF OPPRESSION 1 0.0008
234 RECTAL PROLAPSE 1 0.0008
235 CARDIAC DEATH 1 0.0008
236 LYMPHADENITIS 2 0.0008
237 SCLERODERMA 3 0.0008
238 PHARYNGEAL HAEMORRHAGE 1 0.0008
239 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
240 DENTAL OPERATION 2 0.0008
241 POST-ACUTE COVID-19 SYNDROME 1 0.0008
242 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
243 DUODENAL ULCER PERFORATION 6 0.0008
244 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
245 AMPUTATION 1 0.0008
246 VENOOCCLUSIVE DISEASE 2 0.0008
247 AORTIC VALVE REPLACEMENT 1 0.0008
248 VASODILATATION 2 0.0008
249 CATHETER SITE INFECTION 3 0.0008
250 URINARY TRACT INFECTION BACTERIAL 2 0.0008
251 TROPONIN T INCREASED 1 0.0008
252 HEPATITIS TOXIC 2 0.0008
253 PULMONARY HAEMORRHAGE 6 0.0008
254 COMPARTMENT SYNDROME 2 0.0008
255 ACROCHORDON 1 0.0008
256 POSTPARTUM HAEMORRHAGE 1 0.0007
257 PERIPHERAL ISCHAEMIA 3 0.0007
258 CHOKING SENSATION 4 0.0007
259 ECHOCARDIOGRAM ABNORMAL 1 0.0007
260 ACUTE PULMONARY OEDEMA 4 0.0007
261 TRACHEOSTOMY 1 0.0007
262 DEVICE OPERATIONAL ISSUE 3 0.0007
263 NODAL RHYTHM 1 0.0007
264 HEART VALVE REPLACEMENT 1 0.0007
265 ANGIOPLASTY 1 0.0007
266 MYOSITIS 6 0.0007
267 STEROID DIABETES 1 0.0007
268 HYPERCAPNIA 2 0.0007
269 HEPATITIS CHOLESTATIC 4 0.0007
270 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
271 PALLIATIVE CARE 1 0.0007
272 BLOOD PRESSURE IMMEASURABLE 1 0.0007
273 ISCHAEMIA 3 0.0007
274 CHEST X-RAY ABNORMAL 2 0.0007
275 CARDIOMEGALY 8 0.0006
276 FIBROSIS 2 0.0006
277 PREMATURE SEPARATION OF PLACENTA 1 0.0006
278 LOCALISED OEDEMA 3 0.0006
279 ERYTHEMA MULTIFORME 6 0.0006
280 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
281 HYPOTONIA NEONATAL 1 0.0006
282 MEDICAL DEVICE IMPLANTATION 1 0.0006
283 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
284 CARDIAC TAMPONADE 3 0.0006
285 RESPIRATORY ALKALOSIS 1 0.0006
286 POSTURE ABNORMAL 2 0.0006
287 EXPOSURE DURING BREAST FEEDING 2 0.0006
288 HEPATIC ENZYME ABNORMAL 3 0.0006
289 ENDOCARDITIS 3 0.0006
290 PRODUCT COUNTERFEIT 1 0.0006
291 TREATMENT DELAYED 1 0.0006
292 SKIN NECROSIS 3 0.0006
293 HAEMOPTYSIS 16 0.0006
294 CYANOSIS 9 0.0006
295 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
296 PULMONARY OEDEMA 25 0.0006
297 CARDIOGENIC SHOCK 8 0.0006
298 CALCIPHYLAXIS 1 0.0005
299 PARADOXICAL DRUG REACTION 2 0.0005
300 ADENOCARCINOMA OF COLON 1 0.0005
301 HEPATIC NECROSIS 2 0.0005
302 INFECTED SKIN ULCER 1 0.0005
303 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
304 OESOPHAGEAL DISORDER 2 0.0005
305 PROCEDURAL HAEMORRHAGE 2 0.0005
306 COLOSTOMY 1 0.0005
307 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
308 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
309 IMMUNE-MEDIATED HEPATITIS 1 0.0005
310 OSTEOLYSIS 1 0.0005
311 HYPERTHYROIDISM 7 0.0005
312 MICROCYTIC ANAEMIA 1 0.0005
313 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
314 TRANSFUSION 5 0.0005
315 DEVICE CONNECTION ISSUE 1 0.0005
316 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
317 CATHETER SITE ERYTHEMA 1 0.0005
318 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
319 EXPOSURE DURING PREGNANCY 29 0.0005
320 INFUSION SITE PAIN 6 0.0005
321 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
322 NOSOCOMIAL INFECTION 1 0.0005
323 DYSPNOEA EXERTIONAL 17 0.0005
324 RHEUMATIC FEVER 2 0.0004
325 PSEUDOMEMBRANOUS COLITIS 1 0.0004
326 BRONCHIECTASIS 3 0.0004
327 HEPATOCELLULAR DAMAGE 1 0.0004
328 SUSPECTED OFF LABEL USE 2 0.0004
329 GASTRIC POLYPS 1 0.0004
330 BLOOD LOSS ANAEMIA 1 0.0004
331 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
332 VASCULAR DEVICE INFECTION 2 0.0004
333 HAEMATOCRIT INCREASED 1 0.0004
334 CARDIAC FAILURE 35 0.0004
335 PERICARDIAL EFFUSION 10 0.0004
336 NEUROLOGICAL DECOMPENSATION 1 0.0004
337 AUTOIMMUNE HEPATITIS 3 0.0004
338 INFUSION SITE INFECTION 1 0.0004
339 ESCHERICHIA BACTERAEMIA 1 0.0004
340 TRANSPLANT 1 0.0004
341 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
342 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
343 OXYGEN CONSUMPTION INCREASED 1 0.0004
344 MATERNAL EXPOSURE DURING PREGNANCY 37 0.0004
345 UTERINE LEIOMYOMA 3 0.0004
346 BRONCHITIS CHRONIC 1 0.0004
347 LIVER INJURY 10 0.0004
348 THERAPY CHANGE 4 0.0004
349 FOETAL EXPOSURE DURING PREGNANCY 33 0.0004
350 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
351 GENERALISED OEDEMA 5 0.0004
352 INFLAMMATORY MARKER INCREASED 2 0.0004
353 INJECTION SITE ABSCESS 1 0.0004
354 HYPOXIA 14 0.0004
355 PLATELET DISORDER 1 0.0004
356 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
357 EXCORIATION 1 0.0004
358 HAEMORRHAGE URINARY TRACT 1 0.0004
359 OXYGEN SATURATION DECREASED 22 0.0004
360 CATHETER SITE PAIN 1 0.0004
361 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
362 TRICUSPID VALVE INCOMPETENCE 3 0.0004
363 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
364 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
365 ATRIAL FLUTTER 3 0.0004
366 TRANSPLANT REJECTION 3 0.0004
367 STEATORRHOEA 1 0.0004
368 RHINALGIA 1 0.0004
369 HEPATOTOXICITY 8 0.0004
370 NECK MASS 1 0.0004
371 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
372 EXERCISE TOLERANCE DECREASED 2 0.0003
373 HAEMOTHORAX 1 0.0003
374 ABORTION 1 0.0003
375 DEVICE POWER SOURCE ISSUE 1 0.0003
376 LUNG INFILTRATION 3 0.0003
377 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
378 COVID-19 PNEUMONIA 4 0.0003
379 CARDIOMYOPATHY 5 0.0003
380 THORACIC VERTEBRAL FRACTURE 1 0.0003
381 INFUSION SITE REACTION 1 0.0003
382 FLUID RETENTION 17 0.0003
383 BLOOD BILIRUBIN INCREASED 9 0.0003
384 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
385 LUNG ADENOCARCINOMA 1 0.0003
386 CENTRAL VENOUS CATHETERISATION 1 0.0003
387 BONE MARROW DISORDER 1 0.0003
388 FOETAL GROWTH RESTRICTION 2 0.0003
389 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
390 SEPSIS 36 0.0003
391 EJECTION FRACTION DECREASED 5 0.0003
392 BLOOD BLISTER 1 0.0003
393 PNEUMOTHORAX 5 0.0003
394 ATELECTASIS 3 0.0003
395 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
396 ANGINA UNSTABLE 2 0.0003
397 HEPATITIS ACUTE 2 0.0003
398 CHOKING 6 0.0003
399 HEPATIC NEOPLASM 1 0.0003
400 HEPATOMEGALY 3 0.0003
401 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
402 CYTOLYTIC HEPATITIS 1 0.0003
403 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
404 TOXIC SKIN ERUPTION 3 0.0003
405 BK VIRUS INFECTION 1 0.0003
406 HEPATIC CYST 1 0.0003
407 CIRCULATORY COLLAPSE 5 0.0003
408 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
409 HEPATIC FIBROSIS 1 0.0003
410 DEPRESSION SUICIDAL 1 0.0003
411 GRANULOMA 1 0.0003
412 AORTIC STENOSIS 1 0.0003
413 EXTRASYSTOLES 2 0.0003
414 CAROTID ARTERY STENOSIS 1 0.0003
415 BRONCHIOLITIS 1 0.0003
416 DRUG ERUPTION 5 0.0003
417 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
418 HAEMORRHAGIC DIATHESIS 1 0.0003
419 BRONCHOSPASM 4 0.0003
420 SUBDURAL HAEMATOMA 4 0.0003
421 FACIAL BONES FRACTURE 1 0.0003
422 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
423 LIVER TRANSPLANT 1 0.0003
424 FLUID OVERLOAD 4 0.0003
425 RESPIRATORY FAILURE 20 0.0003
426 VENTRICULAR ARRHYTHMIA 1 0.0003
427 MELAENA 6 0.0003
428 SKIN ULCER 7 0.0003
429 WOUND HAEMORRHAGE 1 0.0003
430 TRANSAMINASES INCREASED 6 0.0003
431 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
432 INTERSTITIAL LUNG DISEASE 13 0.0003
433 RETINOPATHY 1 0.0003
434 RESPIRATORY DISORDER 8 0.0003
435 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
436 FACE INJURY 1 0.0003
437 CARDIO-RESPIRATORY ARREST 11 0.0003
438 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
439 ACUTE RESPIRATORY FAILURE 5 0.0003
440 HYPOTENSION 52 0.0003
441 HAEMOLYSIS 2 0.0003
442 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
443 POST PROCEDURAL HAEMORRHAGE 3 0.0003
444 VASCULITIS 3 0.0003
445 CARDIOPULMONARY FAILURE 1 0.0003
446 TREATMENT NONCOMPLIANCE 14 0.0003
447 WOUND SECRETION 1 0.0003
448 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
449 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
450 RESPIRATORY ACIDOSIS 1 0.0003
451 PNEUMONIA FUNGAL 1 0.0003
452 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
453 INTRACRANIAL ANEURYSM 1 0.0002
454 PLEURAL EFFUSION 15 0.0002
455 OEDEMA PERIPHERAL 30 0.0002
456 PERIPHERAL VENOUS DISEASE 1 0.0002
457 EXTRAVASATION 1 0.0002
458 THYROID FUNCTION TEST ABNORMAL 1 0.0002
459 URINARY RETENTION 8 0.0002
460 OEDEMA 13 0.0002
461 ERECTION INCREASED 1 0.0002
462 LIVE BIRTH 2 0.0002
463 DERMATITIS ALLERGIC 3 0.0002
464 FACE OEDEMA 4 0.0002
465 FACIAL PARALYSIS 2 0.0002
466 LUNG NEOPLASM 1 0.0002
467 MULTI-ORGAN FAILURE 4 0.0002
468 CARDIAC MURMUR 2 0.0002
469 URINE OUTPUT DECREASED 2 0.0002
470 DRUG ADMINISTRATION ERROR 7 0.0002
471 IMMUNE SYSTEM DISORDER 3 0.0002
472 BRADYCARDIA 12 0.0002
473 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
474 RESPIRATORY RATE INCREASED 2 0.0002
475 THERAPY NON-RESPONDER 10 0.0002
476 ABDOMINAL HERNIA 1 0.0002
477 HAEMOGLOBIN INCREASED 1 0.0002
478 LUMBAR VERTEBRAL FRACTURE 1 0.0002
479 PNEUMONIA BACTERIAL 2 0.0002
480 SHOCK 5 0.0002
481 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
482 CONDITION AGGRAVATED 66 0.0002
483 PERFORMANCE STATUS DECREASED 1 0.0002
484 ABORTION INDUCED 2 0.0002
485 DISEASE PROGRESSION 25 0.0002
486 PRE-ECLAMPSIA 1 0.0002
487 PULSE ABSENT 1 0.0002
488 HYPOVOLAEMIC SHOCK 1 0.0002
489 NON-SMALL CELL LUNG CANCER 1 0.0002
490 LIMB OPERATION 1 0.0002
491 GASTROINTESTINAL TOXICITY 1 0.0002
492 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
493 GUILLAIN-BARRE SYNDROME 1 0.0002
494 LIVER FUNCTION TEST ABNORMAL 6 0.0002
495 DIZZINESS POSTURAL 2 0.0002
496 PRESYNCOPE 5 0.0002
497 HORMONE LEVEL ABNORMAL 1 0.0002
498 ASCITES 6 0.0002
499 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
500 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
501 ORGANISING PNEUMONIA 1 0.0002
502 INJECTION SITE INFLAMMATION 1 0.0002
503 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
504 PHLEBITIS 1 0.0002
505 CACHEXIA 1 0.0002
506 CARDIAC ARREST 16 0.0002
507 FOETAL DEATH 1 0.0002
508 VENTRICULAR EXTRASYSTOLES 2 0.0002
509 NERVOUS SYSTEM DISORDER 6 0.0002
510 BLOOD LACTIC ACID INCREASED 1 0.0002
511 RENAL PAIN 2 0.0002
512 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
513 BEHAVIOUR DISORDER 1 0.0002
514 NORMAL NEWBORN 1 0.0002
515 SEPTIC SHOCK 8 0.0002
516 JAW DISORDER 1 0.0002
517 VENTRICULAR TACHYCARDIA 3 0.0002
518 INTESTINAL ISCHAEMIA 1 0.0002
519 DEAFNESS UNILATERAL 1 0.0002
520 HYPERKERATOSIS 1 0.0002
521 LIVER DISORDER 8 0.0002
522 VENTRICULAR FIBRILLATION 2 0.0002
523 HEART RATE ABNORMAL 1 0.0002
524 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
525 SKIN INFECTION 2 0.0002
526 MITRAL VALVE INCOMPETENCE 2 0.0002
527 PAIN IN JAW 5 0.0002
528 GENERALISED ERYTHEMA 1 0.0002
529 BLOOD URIC ACID INCREASED 1 0.0002
530 METASTASES TO LUNG 2 0.0002
531 ORTHOSTATIC HYPOTENSION 3 0.0002
532 EOSINOPHILIA 3 0.0002
533 HYPOVOLAEMIA 1 0.0002
534 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
535 BLOOD IRON DECREASED 2 0.0002
536 GASTROINTESTINAL DISORDER 15 0.0002
537 SYMPTOM RECURRENCE 1 0.0002
538 DRUG ABUSER 1 0.0002
539 PIGMENTATION DISORDER 1 0.0002
540 TOOTH EXTRACTION 2 0.0002
541 INFUSION SITE EXTRAVASATION 1 0.0002
542 SYNCOPE 16 0.0002
543 SECRETION DISCHARGE 2 0.0002
544 INFUSION SITE SWELLING 1 0.0002
545 MULTIPLE INJURIES 1 0.0002
546 FRACTURE 3 0.0002
547 PHOTOPSIA 1 0.0002
548 THERAPEUTIC RESPONSE CHANGED 1 0.0002
549 TACHYCARDIA 14 0.0002
550 INJECTION SITE INDURATION 2 0.0002
551 APPLICATION SITE VESICLES 1 0.0002
552 RESPIRATORY TRACT INFECTION 4 0.0002
553 PLATELET COUNT INCREASED 2 0.0002
554 ASPERGILLUS INFECTION 1 0.0002
555 PULMONARY CONGESTION 2 0.0002
556 CORONAVIRUS INFECTION 1 0.0002
557 CHEST PAIN 28 0.0002
558 BLOOD PRESSURE DECREASED 10 0.0002
559 CARDIAC FAILURE ACUTE 1 0.0001
560 POST-TRAUMATIC STRESS DISORDER 1 0.0001
561 SUICIDE ATTEMPT 9 0.0001
562 ULCER HAEMORRHAGE 1 0.0001
563 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
564 TACHYPNOEA 2 0.0001
565 ECCHYMOSIS 1 0.0001
566 RESPIRATORY DISTRESS 4 0.0001
567 LARGE INTESTINE PERFORATION 1 0.0001
568 HYPERTRANSAMINASAEMIA 1 0.0001
569 HOSPITALISATION 22 0.0001
570 HEPATOCELLULAR INJURY 2 0.0001
571 RETINAL HAEMORRHAGE 1 0.0001
572 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
573 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
574 PRODUCT PRESCRIBING ISSUE 3 0.0001
575 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
576 CEREBRAL DISORDER 1 0.0001
577 FEELING DRUNK 1 0.0001
578 COLITIS ULCERATIVE 6 0.0001
579 IMMUNODEFICIENCY 2 0.0001
580 HEPATIC FUNCTION ABNORMAL 5 0.0001
581 EPISTAXIS 10 0.0001
582 HEPATIC FAILURE 4 0.0001
583 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
584 OSTEOPENIA 2 0.0001
585 DEVICE FAILURE 2 0.0001
586 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
587 LIPASE INCREASED 1 0.0001
588 PROCEDURAL COMPLICATION 1 0.0001
589 RENAL FAILURE CHRONIC 1 0.0001
590 DEVICE RELATED INFECTION 2 0.0001
591 FURUNCLE 1 0.0001
592 BLOOD ALBUMIN DECREASED 1 0.0001
593 SCIATICA 2 0.0001
594 DYSPNOEA 71 0.0001
595 INTENTIONAL OVERDOSE 8 0.0001
596 STENT PLACEMENT 1 0.0001
597 SHOCK HAEMORRHAGIC 1 0.0001
598 ASPHYXIA 1 0.0001
599 CHOLELITHIASIS 4 0.0001
600 ESCHERICHIA INFECTION 1 0.0001
601 MENSTRUAL DISORDER 1 0.0001
602 EMBOLISM 1 0.0001
603 COAGULOPATHY 2 0.0001
604 CELLULITIS 6 0.0001
605 INFUSION SITE ERYTHEMA 1 0.0001
606 HEMIPARESIS 2 0.0001
607 PNEUMONIA 38 0.0001
608 DRUG RESISTANCE 3 0.0001
609 PSEUDOMONAS INFECTION 1 0.0001
610 CARDIAC OPERATION 1 0.0001
611 PSYCHOLOGICAL TRAUMA 1 0.0001
612 HAEMATOMA 3 0.0001
613 DISCOMFORT 7 0.0001
614 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
615 LYMPHADENOPATHY 4 0.0001
616 CARDIOTOXICITY 1 0.0001
617 HAEMOLYTIC ANAEMIA 1 0.0001
618 JAUNDICE 3 0.0001
619 ANAL INCONTINENCE 1 0.0001
620 HEAVY MENSTRUAL BLEEDING 1 0.0001
621 OSTEOMYELITIS 2 0.0001
622 PELVIC PAIN 2 0.0001
623 SKIN LESION 3 0.0001
624 DRUG INTERACTION 17 0.0001
625 FLANK PAIN 1 0.0001
626 HYPONATRAEMIA 6 0.0001
627 PHOTOPHOBIA 2 0.0001
628 BLOOD SODIUM DECREASED 2 0.0001
629 ANGINA PECTORIS 3 0.0001
630 PULMONARY FIBROSIS 2 0.0001
631 POST PROCEDURAL COMPLICATION 2 0.0001
632 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
633 DRUG INTOLERANCE 10 0.0001
634 HYPOGLYCAEMIA 5 0.0001
635 THROMBOTIC MICROANGIOPATHY 1 0.0001
636 NASAL CONGESTION 6 0.0001
637 LUNG DISORDER 5 0.0001
638 MENORRHAGIA 2 0.0001
639 HAEMATOCRIT DECREASED 2 0.0001
640 HYPOTONIA 1 0.0001
641 CYTOKINE RELEASE SYNDROME 2 0.0001
642 APHASIA 3 0.0001
643 EMPHYSEMA 1 0.0001
644 PRODUCT ADMINISTRATION ERROR 2 0.0001
645 HYPOTHERMIA 1 0.0001
646 CHEST DISCOMFORT 10 0.0001
647 INFLAMMATION 5 0.0001
648 HYPERBILIRUBINAEMIA 1 0.0001
649 SUDDEN DEATH 1 0.0001
650 RETCHING 2 0.0001
651 DECREASED ACTIVITY 1 0.0001
652 LACTIC ACIDOSIS 3 0.0001
653 DRUG INEFFECTIVE 122 0.0001
654 PULMONARY THROMBOSIS 1 0.0001
655 IMPAIRED HEALING 3 0.0001
656 HYPERTENSIVE CRISIS 1 0.0001
657 INFLUENZA 10 0.0001
658 PANCYTOPENIA 5 0.0001
659 DEATH 77 0.0001
660 SNEEZING 2 0.0001
661 ANAEMIA 17 0.0001
662 REBOUND EFFECT 1 0.0001
663 OFF LABEL USE 77 0.0001
664 MYOCARDIAL ISCHAEMIA 1 0.0001
665 DERMATITIS CONTACT 1 0.0001
666 MICTURITION URGENCY 1 0.0001
667 INTERNAL HAEMORRHAGE 1 0.0001
668 MYOCARDITIS 1 0.0001
669 GASTRIC HAEMORRHAGE 1 0.0001
670 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
671 ELECTROLYTE IMBALANCE 1 0.0001
672 EYELID OEDEMA 1 0.0001
673 CARDIAC DISORDER 8 0.0001
674 DYSPHONIA 5 0.0001
675 HEART RATE DECREASED 3 0.0001
676 BACTERAEMIA 1 0.0001
677 CHOLECYSTITIS 1 0.0001
678 ACCIDENT 1 0.0001
679 C-REACTIVE PROTEIN INCREASED 3 0.0001
680 COUGH 23 0.0001
681 NO THERAPEUTIC RESPONSE 1 0.0001
682 CEREBRAL INFARCTION 2 0.0001
683 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
684 SMALL INTESTINAL OBSTRUCTION 1 0.0001
685 HYPERCALCAEMIA 1 0.0001
686 THROMBOCYTOPENIA 9 0.0001
687 PNEUMONIA ASPIRATION 2 0.0001
688 INJECTION SITE DISCOLOURATION 1 0.0001
689 INTESTINAL OBSTRUCTION 3 0.0001
690 ABDOMINAL PAIN LOWER 2 0.0001
691 HAEMATEMESIS 2 0.0001
692 HEPATITIS 2 0.0001
693 GENITAL HAEMORRHAGE 1 0.0001
694 PALPITATIONS 9 0.0001
695 SWELLING FACE 5 0.0001
696 ABDOMINAL DISTENSION 8 0.0001
697 PRODUCT DOSE OMISSION 5 0.0001
698 DEAFNESS 2 0.0001
699 MUSCULOSKELETAL PAIN 4 0.0001
700 QUALITY OF LIFE DECREASED 1 0.0001
701 PRODUCT USE ISSUE 14 0.0001
702 FEAR 2 0.0001
703 SINUS CONGESTION 1 0.0001
704 PALLOR 2 0.0001
705 DRUG TOXICITY 1 0.0001
706 HEPATIC ENZYME INCREASED 5 0.0001
707 MOOD ALTERED 2 0.0001
708 RESPIRATORY ARREST 2 0.0001
709 FEELING COLD 2 0.0001
710 RENAL IMPAIRMENT 6 0.0001
711 PERIPHERAL SWELLING 11 0.0001
712 DEVICE OCCLUSION 1 0.0001
713 LYMPHOPENIA 1 0.0001
714 SINUS TACHYCARDIA 1 0.0001
715 HYPERSOMNIA 2 0.0001
716 IMPAIRED QUALITY OF LIFE 1 0.0001
717 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
718 GASTROENTERITIS 1 0.0001
719 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
720 HAEMOGLOBIN DECREASED 7 0.0001
721 ACUTE MYOCARDIAL INFARCTION 2 0.0001
722 PULMONARY MASS 1 0.0001
723 HYPOAESTHESIA ORAL 1 0.0001
724 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
725 TINNITUS 3 0.0001
726 SKIN DISCOLOURATION 3 0.0001
727 FEELING HOT 4 0.0001
728 PHARYNGEAL OEDEMA 1 0.0001
729 LUNG INFECTION 1 0.0001
730 COGNITIVE DISORDER 3 0.0001
731 ACUTE MYELOID LEUKAEMIA 1 0.0001
732 THERAPY PARTIAL RESPONDER 1 0.0001
733 VOMITING 30 0.0001
734 PRODUCT USE COMPLAINT 1 0.0001
735 ARRHYTHMIA 3 0.0001
736 HEAD INJURY 2 0.0001
737 ABDOMINAL PAIN UPPER 13 0.0001
738 DISEASE RECURRENCE 3 0.0001
739 ULCER 1 0.0001
740 PRODUCTIVE COUGH 3 0.0001
741 LOSS OF CONSCIOUSNESS 8 0.0001
742 STAPHYLOCOCCAL INFECTION 2 0.0001
743 HEADACHE 38 0.0001
744 SEIZURE 7 0.0001
745 TREATMENT FAILURE 5 0.0001
746 LEUKOPENIA 3 0.0001
747 SKIN DISORDER 2 0.0001
748 BLOOD UREA INCREASED 1 0.0001
749 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
750 FLUSHING 6 0.0001
751 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
752 METRORRHAGIA 1 0.0001
753 HAEMORRHAGE 6 0.0001
754 BURNING SENSATION 4 0.0001
755 COVID-19 10 0.0001
756 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
757 HEAD DISCOMFORT 1 0.0001
758 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
759 ISCHAEMIC STROKE 1 0.0001
760 ABDOMINAL PAIN 13 0.0001
761 HAEMATOCHEZIA 3 0.0001
762 HEPATIC STEATOSIS 1 0.0001
763 BACTERIAL INFECTION 1 0.0001
764 HEPATIC CIRRHOSIS 1 0.0001
765 HYPOCALCAEMIA 1 0.0001
766 PROTEINURIA 1 0.0001
767 SLEEP APNOEA SYNDROME 1 0.0001
768 HERPES ZOSTER 3 0.0001
769 LETHARGY 3 0.0001
770 HERNIA 1 0.0001
771 DISABILITY 1 0.0001
772 HEART RATE INCREASED 5 0.0001
773 PREGNANCY 1 0.0000
774 CARDIAC FAILURE CONGESTIVE 4 0.0000
775 THROMBOSIS 4 0.0000
776 JOINT SWELLING 6 0.0000
777 FEEDING DISORDER 1 0.0000
778 NASOPHARYNGITIS 9 0.0000
779 PRODUCT PREPARATION ERROR 1 0.0000
780 OSTEOPOROSIS 2 0.0000
781 PERITONITIS 1 0.0000
782 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
783 INTENTIONAL DRUG MISUSE 1 0.0000
784 ROAD TRAFFIC ACCIDENT 2 0.0000
785 DERMATITIS 1 0.0000
786 MOUTH ULCERATION 1 0.0000
787 HALLUCINATION, VISUAL 1 0.0000
788 RENAL FAILURE ACUTE 2 0.0000
789 LIVER FUNCTION TEST INCREASED 1 0.0000
790 DIARRHOEA 30 0.0000
791 FAECES DISCOLOURED 1 0.0000
792 BLOOD CREATININE INCREASED 3 0.0000
793 INTENTIONAL PRODUCT MISUSE 4 0.0000
794 INFUSION RELATED REACTION 3 0.0000
795 ANGIOEDEMA 2 0.0000
796 RASH MACULO-PAPULAR 1 0.0000
797 WEIGHT INCREASED 10 0.0000
798 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
799 PRODUCT AVAILABILITY ISSUE 1 0.0000
800 HYPOKALAEMIA 2 0.0000
801 BACK PAIN 10 0.0000
802 RENAL DISORDER 2 0.0000
803 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
804 SWELLING 4 0.0000
805 PRODUCT PRESCRIBING ERROR 1 0.0000
806 NAUSEA 33 0.0000
807 INFECTION 6 0.0000
808 NEURALGIA 1 0.0000
809 URINARY TRACT INFECTION 7 0.0000
810 BRONCHITIS 3 0.0000
811 ABASIA 1 0.0000
812 PYREXIA 14 0.0000
813 AGGRESSION 2 0.0000
814 SINUSITIS 4 0.0000
815 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
816 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
817 ANAPHYLACTIC SHOCK 1 0.0000
818 MALAISE 17 0.0000
819 UNRESPONSIVE TO STIMULI 1 0.0000
820 DRUG DOSE OMISSION BY DEVICE 3 0.0000
821 SPEECH DISORDER 2 0.0000
822 APPLICATION SITE ERYTHEMA 1 0.0000
823 PANCREATITIS 2 0.0000
824 RENAL FAILURE 5 0.0000
825 PAIN 23 0.0000
826 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
827 PNEUMONITIS 1 0.0000
828 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
829 INFLUENZA LIKE ILLNESS 3 0.0000
830 TREMOR 6 0.0000
831 DIZZINESS 18 0.0000
832 TOXICITY TO VARIOUS AGENTS 6 0.0000
833 SKIN EXFOLIATION 3 0.0000
834 ERYTHEMA 7 0.0000
835 PAIN IN EXTREMITY 10 0.0000
836 CATARACT 2 0.0000
837 IRRITABILITY 2 0.0000
838 BLOOD POTASSIUM DECREASED 1 0.0000
839 FALL 11 0.0000
840 CORONARY ARTERY DISEASE 1 0.0000
841 LIMB DISCOMFORT 1 0.0000
842 VISUAL IMPAIRMENT 4 0.0000
843 SWOLLEN TONGUE 1 0.0000
844 DYSPHAGIA 3 0.0000
845 CYSTITIS 1 0.0000
846 METABOLIC ACIDOSIS 1 0.0000
847 HYPERHIDROSIS 4 0.0000
848 NIGHT SWEATS 1 0.0000
849 RHINORRHOEA 2 0.0000
850 ATRIAL FIBRILLATION 3 0.0000
851 PRODUCT DOSE OMISSION ISSUE 9 0.0000
852 DEHYDRATION 4 0.0000
853 RASH 13 0.0000
854 MYALGIA 5 0.0000
855 FEELING ABNORMAL 7 0.0000
856 HAEMATURIA 1 0.0000
857 GASTRIC DISORDER 1 0.0000
858 MYOCARDIAL INFARCTION 5 0.0000
859 RASH MACULAR 1 0.0000
860 HYPERKALAEMIA 1 0.0000
861 DEVICE MALFUNCTION 2 0.0000
862 ANXIETY 8 0.0000
863 CEREBRAL HAEMORRHAGE 1 0.0000
864 SKIN BURNING SENSATION 2 0.0000
865 PANIC ATTACK 1 0.0000
866 UNDERDOSE 2 0.0000
867 AGITATION 2 0.0000
868 FATIGUE 21 0.0000
869 EYE SWELLING 1 0.0000
870 RHEUMATOID ARTHRITIS 3 0.0000
871 DIABETES MELLITUS 2 0.0000
872 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
873 PARAESTHESIA 4 0.0000
874 WEIGHT DECREASED 7 0.0000
875 SOMNOLENCE 5 0.0000
876 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
877 DEVICE BREAKAGE 1 0.0000
878 NEUTROPHIL COUNT DECREASED 1 0.0000
879 DRUG DOSE OMISSION 4 0.0000
880 RHABDOMYOLYSIS 1 0.0000
881 ASTHENIA 9 0.0000
882 CEREBROVASCULAR ACCIDENT 4 0.0000
883 RECTAL HAEMORRHAGE 1 0.0000
884 VAGINAL HAEMORRHAGE 1 0.0000
885 MENTAL DISORDER 1 0.0000
886 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
887 DRY SKIN 3 0.0000
888 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
889 THROAT IRRITATION 1 0.0000
890 NEUTROPENIA 3 0.0000
891 DEPRESSION 5 0.0000
892 SKIN IRRITATION 1 0.0000
893 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
894 HYPERSENSITIVITY 4 0.0000
895 BLOOD CHOLESTEROL INCREASED 1 0.0000
896 PULMONARY EMBOLISM 2 0.0000
897 COMA 1 0.0000
898 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
899 DYSPEPSIA 2 0.0000
900 DRY EYE 1 0.0000
901 ACUTE KIDNEY INJURY 3 0.0000
902 THERAPY CESSATION 1 0.0000
903 ILLNESS 2 0.0000
904 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
905 NERVOUSNESS 1 0.0000
906 DEPRESSED MOOD 1 0.0000
907 PLATELET COUNT DECREASED 2 0.0000
908 RASH PRURITIC 1 0.0000
909 PRURITUS 7 0.0000
910 ANAPHYLACTIC REACTION 1 0.0000
911 EYE PAIN 1 0.0000
912 ASTHMA 2 0.0000
913 CONVULSION 1 0.0000
914 DECREASED APPETITE 4 0.0000
915 SURGERY 1 0.0000
916 WHEEZING 1 0.0000
917 ARTHRALGIA 7 0.0000
918 NO ADVERSE EVENT 3 0.0000
919 THERAPEUTIC RESPONSE DECREASED 1 0.0000
920 STOMATITIS 1 0.0000
921 ILL-DEFINED DISORDER 1 0.0000
922 VERTIGO 1 0.0000
923 INJECTION SITE PAIN 5 0.0000
924 INJECTION SITE ERYTHEMA 2 0.0000
925 GAIT DISTURBANCE 3 0.0000
926 AMNESIA 1 0.0000
927 INSOMNIA 4 0.0000
928 INJECTION SITE PRURITUS 1 0.0000
929 INJECTION SITE REACTION 1 0.0000
930 SLEEP DISORDER 1 0.0000
931 HYPERTENSION 3 0.0000
932 DYSGEUSIA 1 0.0000
933 HOT FLUSH 1 0.0000
934 UNEVALUABLE EVENT 1 0.0000
935 CHRONIC KIDNEY DISEASE 1 0.0000
936 INJECTION SITE HAEMORRHAGE 1 0.0000
937 CONFUSIONAL STATE 2 0.0000
938 URTICARIA 2 0.0000
939 ABDOMINAL DISCOMFORT 2 0.0000
940 BALANCE DISORDER 1 0.0000
941 MUSCULOSKELETAL STIFFNESS 1 0.0000
942 ADVERSE DRUG REACTION 1 0.0000
943 ADVERSE EVENT 1 0.0000
944 OROPHARYNGEAL PAIN 1 0.0000
945 BREAST CANCER 1 0.0000
946 NEUROPATHY PERIPHERAL 1 0.0000
947 MIGRAINE 1 0.0000
948 CONTUSION 1 0.0000
949 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
950 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
951 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
952 CONSTIPATION 2 0.0000
953 INCORRECT DOSE ADMINISTERED 2 0.0000
954 CHILLS 1 0.0000
955 MEMORY IMPAIRMENT 1 0.0000
956 HYPOAESTHESIA 1 0.0000
957 MUSCLE SPASMS 1 0.0000
958 ALOPECIA 1 0.0000
959 OVERDOSE 1 0.0000